Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties.  Since innovation is the lifeblood of the medical research industry, Boston Scientific develops treatment technology in multiple fields including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific’s Neuromodulation business is the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain. The use of minute pulses of electricity delivered directly to nerves, known as spinal cord stimulation, has been in use for more than 30 years. Without the unwanted side effects and long-term costs associated with pain medications, and less invasive than surgical procedures such as spinal fusion. The Neuromodulation business located here in Valencia employs 1250 people worldwide that provide spinal cord stimulation products.
The division continues to expand worldwide and are developing new practice areas that serve unmet patient needs and demonstrate clinical value.  Boston Scientific believes that its success “is a strong indicator of both product quality and customer loyalty,” and it bodes well at a time when supplier consolidation and physician employment by hospitals are becoming a common industry practice.
Lisa Welker-Finney, Vice President of Human Resources shared “this is a unique and wonderful community in which we live and work.  We are very honored and thankful to the gracious community members who submitted a nomination of our behalf.  This community is strong and vital and helps us maintain our competitive advantage in innovation.”

 

25155 Rye Canyon Loop, Valencia
www.bostonscientific.com
661-949-4542